Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Cytryn SL, Moy RH, Cowzer D, Shah RH, Chou JF, Joshi SS, Ku GY, Maron SB, Desai A, Yang J, Sugarman R, Rao D, Goldberg Z, Charalambous C, Lapshina M, Antoine A, Socolow F, Trivedi N, Capanu M, Gerdes H, Schattner MA, Simmons M, Lacouture ME, Paroder V, Tang LH, Shia J, Ilson DH, Solit DB, Berger MF, Janjigian YY. Cytryn SL, et al. Among authors: lacouture me. Lancet Oncol. 2023 Oct;24(10):1073-1082. doi: 10.1016/S1470-2045(23)00358-3. Epub 2023 Sep 1. Lancet Oncol. 2023. PMID: 37666264 Free PMC article. Clinical Trial.
A five arm natural history study of nasal vestibulitis.
Cathcart-Rake EJ, Zahrieh D, Smith D, Young S, McCue S, O'Connor A, Thomé S, Lacouture M, Register T, Piens J, Friday BB, Loprinzi CL. Cathcart-Rake EJ, et al. Cancer Med. 2023 Apr;12(8):9650-9654. doi: 10.1002/cam4.5887. Epub 2023 Apr 5. Cancer Med. 2023. PMID: 37017603 Free PMC article.
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.
Gu S, Dusza S, Quigley E, Haliasos H, Markova A, Marchetti M, Moy AP, Dang C, Modi S, Lake D, Noor S, Lacouture ME. Gu S, et al. Among authors: lacouture me. Breast Cancer Res Treat. 2024 Jan;203(2):271-280. doi: 10.1007/s10549-023-07143-3. Epub 2023 Oct 13. Breast Cancer Res Treat. 2024. PMID: 37833451 Free PMC article.
Omalizumab for Treatment of Anti-GD2 Antibody-related Urticaria.
Glincher R, Lentini-Rivera A, Andre Jones L, D'Andrea L, Durney C, Kasper C, Lin Y, Shrager L, Markova A, Lacouture M, Modak S. Glincher R, et al. J Pediatr Hematol Oncol. 2024 Oct 1;46(7):e531-e533. doi: 10.1097/MPH.0000000000002939. Epub 2024 Aug 22. J Pediatr Hematol Oncol. 2024. PMID: 39177945
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms.
Reiner AS, Durham BH, Yabe M, Petrova-Drus K, Francis JH, Rampal RK, Lacouture ME, Rotemberg V, Abdel-Wahab O, Panageas KS, Diamond EL. Reiner AS, et al. Among authors: lacouture me. Br J Haematol. 2023 Nov;203(3):389-394. doi: 10.1111/bjh.18964. Epub 2023 Jul 3. Br J Haematol. 2023. PMID: 37400251 Free PMC article.
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
Zhao JL, Antonarakis ES, Cheng HH, George DJ, Aggarwal R, Riedel E, Sumiyoshi T, Schonhoft JD, Anderson A, Mao N, Haywood S, Decker B, Curley T, Abida W, Feng FY, Knudsen K, Carver B, Lacouture ME, Wyatt AW, Rathkopf D. Zhao JL, et al. Among authors: lacouture me. Br J Cancer. 2024 Jan;130(1):53-62. doi: 10.1038/s41416-023-02487-5. Epub 2023 Nov 18. Br J Cancer. 2024. PMID: 37980367 Free PMC article. Clinical Trial.
Oral minoxidil for late alopecia in cancer survivors.
Kuo AM, Reingold RE, Ketosugbo KF, Pan A, Kraehenbuehl L, Dusza S, Gajria D, Lake DE, Bromberg JF, Traina TA, Fornier MN, Gucalp A, D'Alessandro BM, Rotemberg V, Dauscher M, Shapiro J, Goldfarb SB, Markova A, Lacouture ME. Kuo AM, et al. Among authors: lacouture me. Breast Cancer Res Treat. 2024 Dec;208(3):491-499. doi: 10.1007/s10549-024-07440-5. Epub 2024 Aug 4. Breast Cancer Res Treat. 2024. PMID: 39097564
285 results